Found 4363 articles for: ""
Inflammation of Seborrheic Keratoses Caused by Cytarabine: A Pseudo Sign of Leser-Trelat
September 2004 | Volume 3 | Issue 5 | Case Reports | 565 | Copyright © September 2004
Cytarabine, used for the treatment of acute myelogenous leukemia, can cause a rare reaction of inflammation of existing seborrheic keratoses. We report a case of cytarabine induced inflammation of se...
Read MoreSteroid-free Pimecrolimus (Elidel) for Monotherapy of Lichen Planus
September 2004 | Volume 3 | Issue 5 | Case Reports | 563 | Copyright © September 2004
Lichen planus (LP) is a disease distinguished by pruitic violaceous planar papules containing reticulated white striae. It can occur just about anywhere, but most commonly occurs in the mouth, genita...
Read MoreUndifferentiated Connective Tissue Disease with Various Pigmentary Patterns: A Study of Three Patients
September 2004 | Volume 3 | Issue 5 | Case Reports | 560 | Copyright © September 2004
Undifferentiated connective tissue disease (UCTD) is a condition characterized by the presence of clinical manifestations suggestive of a connective tissue disease and at least one non-organ specific...
Read MoreFlexural Bazex syndrome associated with Tonsillar Adenocarcinoma
September 2004 | Volume 3 | Issue 5 | Case Reports | 557 | Copyright © September 2004
Bazex Syndrome (acrokeratosis paraneoplastica) is characterized by a psoriasiform skin eruption that favors acral sites and has been associated with underlying malignancy in all reported cases. Squam...
Read MorePrednicarbate (Dermatop®): A review
September 2004 | Volume 3 | Issue 5 | Original Article | 553 | Copyright © September 2004
Prednicarbate is a non-halogenated, double-ester derivative of prednisolone that has become of interest for the treatment of inflammatory skin diseases, for example atopic dermatitis. In the past, to...
Read MoreLaser-Mediated Photodynamic Therapy of Actinic Cheilitis
September 2004 | Volume 3 | Issue 5 | Original Article | 548 | Copyright © September 2004
Actinic cheilitis (AC) is a common precancerous condition for which a safe, effective, rapid, and cosmetically favorable treatment is needed. The objective of this study was to assess the safety and ...
Read MoreFacial Enhancement and the European Experience with Sculptra (Poly-L-lactic Acid)
September 2004 | Volume 3 | Issue 5 | Original Article | 542 | Copyright © September 2004
The primary reason patients seek aesthetic treatments is to combat the signs of aging. However, the majority of facial treatments and procedures fill specific wrinkles or pull-taught sagging skin, wi...
Read MoreImmunomodulators for Skin Cancer
September 2004 | Volume 3 | Issue 5 | Original Article | 533 | Copyright © September 2004
Therapeutic interventions to augment tumor antigenicity or increase the host’s immune response against cancer cells include recombinant cytokines, immune modulators, vaccination with tumor antigens...
Read MoreThe Excimer Lasers
September 2004 | Volume 3 | Issue 5 | Original Article | 522 | Copyright © September 2004
The excimer lasers are a group of lasers that have found wide application in a variety of medical fields including dermatology, cardiology, ophthalmology, and orthopedics. The word excimer refers to ...
Read MorePrimary Prevention Efforts for Melanoma
September 2004 | Volume 3 | Issue 5 | Original Article | 506 | Copyright © September 2004
Oral Isotretinoin in the Treatment and Prevention of Cutaneous Squamous Cell Carcinoma
September 2004 | Volume 3 | Issue 5 | Original Article | 498 | Copyright © September 2004
The clinical uses of oral isotretinoin (13-cis-retinoic acid) are many. They include treatment of acneiform eruptions, diseases of cornification, inflammatory disorders, and neoplastic processes. Iso...
Read MoreComputerized Image Analysis of Nails Affected by Fungal Infection: Evaluation Using Digital Photographs and Manually Defined Areas
September 2004 | Volume 3 | Issue 5 | Original Article | 489 | Copyright © September 2004
Despite the relevant increase in clinical trials on the efficacy of various systemic and/or topical antifungal agents in onychomycosis therapy, the evaluation of the results is largely subjective. Th...
Read MoreClinical Trial Review
July 2004 | Volume 3 | Issue 4 | Features | 462 | Copyright © July 2004
Washington Whispers
July 2004 | Volume 3 | Issue 4 | Features | 460 | Copyright © July 2004
Pipeline Previews
July 2004 | Volume 3 | Issue 4 | Features | 456 | Copyright © July 2004
A Dramatic Change in HIV Treatment
July 2004 | Volume 3 | Issue 4 | Case Reports | 452 | Copyright © July 2004
Impetigo Herpetiformis in a Primigravida: Successful Treatment with Etretinate
July 2004 | Volume 3 | Issue 4 | Case Reports | 449 | Copyright © July 2004
Impetigo herpetiformis (IH) is a rare dermatosis which usually occurs during the third trimester of pregnancy. It is characterized by acute erythematosquamous plaques covered with tiny superficial pu...
Read MoreElephantiasis Nostrum Verrucosa of the Abdomen: Clinical Results with Tazarotene
July 2004 | Volume 3 | Issue 4 | Case Reports | 446 | Copyright © July 2004
Elephantiasis nostras verrucosa represents an uncommon yet distinct clinical entity resulting from chronic lymphedema of an extremity or body region. Characterized by profound non-pitting edema with ...
Read MoreTreatment of Pyoderma Gangrenosum with Etanercept
July 2004 | Volume 3 | Issue 4 | Case Reports | 441 | Copyright © July 2004
We describe a patient with pyoderma gangrenosum (PG) whose lesions responded to etanercept therapy. This disease has been recognized for diverse underlying pathology and associated immune disturbance...
Read MorePustular Psoriasis Induced by Infliximab
July 2004 | Volume 3 | Issue 4 | Case Reports | 439 | Copyright © July 2004
Pustular psoriasis is an uncommon variant of psoriasis characterized by widespread pustules on an erythematous background. Recent reports document the efficacy of immunobiologic agents such as inflix...
Read More